Results 231 to 240 of about 1,360,432 (251)

Challenges of Dengue in Hematological Disease Patients: Descriptive Analysis From the DANGO Registry During the 2023–2024 Outbreak in Argentina

open access: yesTransplant Infectious Disease, EarlyView.
During the 2023–2024 Argentine dengue outbreak, 33 patients with hematological disease showed high complication rates, frequent hospitalization (64%), severe thrombocytopenia (90%), and 6% dengue‐attributable mortality. Transfusion‐associated cases were documented.
Gustavo Adolfo Méndez   +16 more
wiley   +1 more source

Evaluating the effects of a hospital utilisation improvement program on platelet transfusions: A pre‐post study

open access: yesTransfusion Medicine, EarlyView.
Abstract Background Annually millions of platelet concentrate (PC) are transfused worldwide. The decision regarding PC transfusion is often complex; therefore, the implementation of a hospital programme designed to streamline and facilitate the decision‐making process is beneficial. Such a programme helps standardise transfusion practices, ensures that
Piotr F. Czempik   +2 more
wiley   +1 more source

A retrospective analysis of the antigen‐negative red blood cell supply conducted at a single centre in China

open access: yesTransfusion Medicine, EarlyView.
Abstract Objective This study aimed to analyse the distribution and demand patterns of antigen‐negative red blood cells (RBCs) in Shandong Province, China (2022–2024), with a focus on ABO blood groups and clinically significant antigens. The research was designed to provide rigorous data for advancing precision transfusion protocols and to establish a ...
Aiping Zhao   +7 more
wiley   +1 more source

Functional validation of a modified platelet desialylation test for immune and hereditary thrombocytopenias

open access: yesTransfusion Medicine, EarlyView.
Abstract Background Thrombocytopenia arises from heterogeneous inherited and acquired disorders, and identifying the underlying platelet clearance mechanisms remains challenging. Platelet desialylation, characterised by loss of sialic acid and consequent exposure of terminal β‐galactose residues recognised by the Ashwell–Morell receptor, represents an ...
Karen Nogueira Chinoca Ziza   +14 more
wiley   +1 more source

Adverse transfusion reactions and what we can do

Expert Review of Hematology, 2022
Quan Rao
exaly  

Transfusion Reactions and Adverse Events

Clinics in Laboratory Medicine, 2021
Sandhya R Panch
exaly  

Transfusion therapy

Ca-A Cancer Journal for Clinicians, 1986
B Lichtiger
exaly  

Transfusion therapy for patients with cancer

Ca-A Cancer Journal for Clinicians, 1985
Yang Huh   +2 more
exaly  

Pathobiology of Transfusion Reactions

Annual Review of Pathology: Mechanisms of Disease, 2015
James C Zimring, Steven L. Spitalnik
exaly  

Adverse Reactions to Transfusion of Blood Products and Best Practices for Prevention

Critical Care Nursing Clinics of North America, 2017
Andrew Bugajski   +2 more
exaly  

Home - About - Disclaimer - Privacy